Fund Holdings — Catalio Capital Management, LP

Total Portfolio Value
$540.93M
Total Bought
$171.32M
Total Sold
$179.38M
Net Transaction
-$8.07M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
ABBVIE INC(ABBV)0154,834+154,834035,8506.63%+35,850
REGENERON PHARMACEUTICALS(REGN)035,344+35,344019,8733.67%+19,873
ABIVAX SA(ABVX)0162,141+162,141013,7662.54%+13,766
SUPERNUS PHARMACEUTICALS INC(SUPN)0287,090+287,090013,7202.54%+13,720
EXACT SCIENCES CORP(EXK)0248,987+248,987013,6222.52%+13,622
DISC MEDICINE INC(IRON)30,661216,527+185,8661,62414,3082.65%+12,684
DIANTHUS THERAPEUTICS INC(DNTH)746,527667,615-78,91213,90826,2714.86%+12,363
AVIDITY BIOSCIENCES INC0263,256+263,256011,4702.12%+11,470
UNIQURE NV(QURE)417,443282,940-134,5035,81916,5153.05%+10,696
GRAIL INC(GRAL)0137,928+137,92808,1561.51%+8,156
FRACTYL HEALTH INC(GUTS)214,2365,214,236+5,000,0003478,2911.53%+7,944
NATERA INC(NTRA)97,297148,369+51,07216,43723,8834.42%+7,446
PHATHOM PHARMACEUTICALS INC(PHAT)672,2901,128,521+456,2316,44713,2832.46%+6,835
SYNDAX PHARMACEUTICALS INC(SNDX)2,104,5121,614,717-489,79519,70924,8424.59%+5,134
CIDARA THERAPEUTICS INC053,333+53,33305,1070.94%+5,107
CYTOKINETICS INC(CYTK)601,439451,581-149,85819,87224,8194.59%+4,947
STRUCTURE THERAPEUTICS INC670,575651,810-18,76513,90818,2513.37%+4,343
ELEDON PHARMACEUTICALS INC(ELDN)01,061,132+1,061,13202,7480.51%+2,748
SEPTERNA INC(SEPN)294,360294,36003,1115,5371.02%+2,426
ELI LILLY & CO(LLY)53,91657,376+3,46042,02943,7788.09%+1,749
KYVERNA THERAPEUTICS INC(KYTX)586,909586,90901,8023,5210.65%+1,720
PROTARA THERAPEUTICS INC(TARA)1,626,3701,500,793-125,5774,9286,5281.21%+1,601
INTUITIVE SURGICAL INC56,67471,343+14,66930,79731,9075.90%+1,110
BOSTON SCIENTIFIC CORP(BSX)229,046262,972+33,92624,60225,6744.75%+1,072
ULTRAGENYX PHARMACEUTICAL IN(RARE)213,402291,262+77,8607,7598,7611.62%+1,002
PALVELLA THERAPEUTICS INC NE(PVLA)012,010+12,01007530.14%+753
ATAI LIFE SCIENCES NV196,858196,85804311,0410.19%+610
METAGENOMI INC(MGX)528,993528,99307831,2540.23%+471
HYPERFINE INC(HYPR)760,035684,541-75,4945479930.18%+446
KARYOPHARM THERAPEUTICS INC(KPTI)146,013142,984-3,0296299350.17%+306
SENSEI BIOTHERAPEUTICS INC(FTH)14,71814,71801261390.03%+13
ADMA BIOLOGICS INC569,704684,508+114,80410,37410,0351.86%-339
MERSANA THERAPEUTICS INC1,567,4130-1,567,4134640—-464
BICARA THERAPEUTICS INC97,8000-97,8009090—-909
FULCRUM THERAPEUTICS INC(FULC)188,3040-188,3041,2960—-1,296
OUTSET MED INC(OM)166,666118,279-48,3873,2021,6700.31%-1,532
VIR BIOTECHNOLOGY INC(VIR)388,3030-388,3031,9570—-1,957
ZENAS BIOPHARMA INC(ZBIO)215,3140-215,3142,0860—-2,086
ASCENDIS PHARMA A/S(ASND)179,926144,954-34,97231,05528,8185.33%-2,237
ADAPTIVE BIOTECHNOLOGIES COR(ADPT)1,396,445884,890-511,55516,26913,2382.45%-3,031
REPLIMUNE GROUP INC(REPL)330,3370-330,3373,0690—-3,069
GENEDX HOLDINGS CORP(WGS)61,5070-61,5075,6780—-5,678
SOLENO THERAPEUTICS INC409,944418,245+8,30134,34528,2735.23%-6,072
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)162,596133,131-29,4657,6759550.18%-6,720
BRIDGEBIO PHARMA INC(BBIO)927,711622,729-304,98240,05932,3455.98%-7,714
HALOZYME THERAPEUTICS INC(HALO)191,5290-191,5299,9630—-9,963
CORCEPT THERAPEUTICS INC(CORT)239,1250-239,12517,5520—-17,552
TEVA PHARMACEUTICAL INDS LTD(TEVA)1,170,3720-1,170,37219,6150—-19,615
GILEAD SCIENCES INC(GILD)226,8750-226,87525,1540—-25,154
EDWARDS LIFESCIENCES CORP390,9320-390,93230,5750—-30,575
Page 1 of 1
Catalio Capital Management, LP — 13F Holdings — Q3 2025 | TickerTrail